Infographic: Brain Infection and Alzheimer’s Disease Pathology

Emerging evidence links bacterial or viral infection with the neuropathology of Alzheimer’s disease.

By | September 1, 2017

© KIMBERLY BATTISTA

Numerous studies on postmortem brains have found evidence of infection, such as biofilms, in the same regions as Alzheimer’s neurodegeneration—namely, the hippocampus and temporal lobe (1). There are  some data that suggest the pathogens themselves can produce amyloid precursor protein (APP), which is processed into amyloid-β by the cell (2). More commonly, researchers have blamed the innate immune system—triggered by the pathogens once they enter the brain—for Alzheimer’s pathology. The activation of Toll-like receptor 2, for example, triggers the release of proinflammatory cytokines by microglial cells (3). These immune responses help protect brain from the infection, but they can also cause collateral damage—such as the death of nearby neurons. In addition, amyloid-β, produced by nearby neurons, may be an antimicrobial peptide that gets recruited to fight the pathogen; the peptide surrounds and seals off the pathogen (4). Some pathogens form a biofilm that is impenetrable to the immune system. Alternatively, some researchers think that infection affects neural processing of APP, leading to an overproduction and then aggregation of amyloid-β (5), a telltale sign of Alzheimer’s disease.

© KIMBERLY BATTISTA

Read the full story.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. A Newly Identified Species Represents Its Own Eukaryotic Lineage
  2. Telomere Length and Childhood Stress Don’t Always Correlate
  3. Optogenetic Therapies Move Closer to Clinical Use
  4. Research Links Gut Health to Neurodegeneration
    The Nutshell Research Links Gut Health to Neurodegeneration

    Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

RayBiotech